HNN3.0
Register
Register
Register

Project cooperationUpdated on 6 January 2026

AI-Driven Data Analytics & Methodological Partner for R&D Projects

Professor of Biostatistics at DataVerse Scientific Solutions

Ankara, Türkiye

About

We are seeking project cooperation opportunities in national and international research and innovation programmes, especially EU-funded projects (e.g. Horizon Europe, Erasmus+, COST). DataVerse A.Ş. is a technology company established in 2022 by three experienced academicians based at Ankara University Technopolis, providing expert statistical consulting, advanced data analysis, AI/ML modelling, research design, and training services. Our expertise spans biostatistics, machine learning, decision support systems, clinical research design, psychometrics, and computer-adaptive testing. We have supported over a thousand scientific studies, organized numerous professional trainings, and participated in nearly forty national and international projects. We are keen to collaborate as a partner in multidisciplinary consortia, contributing to work packages in data analytics, methodological innovation, and capacity building.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

Organisation

DataVerse Scientific Solutions

Company (SME)

Ankara, Türkiye

Similar opportunities

  • Project cooperation

    Consortium partner looking for HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Cristy Verzijl

    Postdoctoral researcher CardioMetabolic diseases at University Medical Center Groningen

    Groningen, Netherlands

  • Project cooperation

    Cardiovascular disease and endometriosis

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Frauke von Versen

    Physician-scientist at Medizinische Hochschule Hannover

    Hannover, Germany

  • Project cooperation

    Bioinformatics/IT SME partner with expertise in genetic/genomics dataanalysis.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    David Atlan

    CEO at Phenosystems SA

    Blonay, Switzerland